Reining in Renal Cancer
June 09, 2009 – Karen Patterson
Conquering Cancer & the Classroom
June 09, 2009 – Scott Williams
Targeted Therapy: Hope or Hype?
June 09, 2009 – Laura Beil
Message from the Editor
June 09, 2009 – Debu Tripathy, MD
Letters from Our Readers
June 09, 2009
All Is Not Lost
June 09, 2009 – Lacey Meyer
Medical Devices Face Stricter Regulations
June 09, 2009 – Jo Cavallo
Good Grilling
June 09, 2009 – Lena Huang
A Life Beyond Cancer
June 09, 2009 – Renée La Forest
Prostate, Brain & Kidney Cancers
June 09, 2009 – Elizabeth Whittington
Revisiting the Seasons of Survival
June 09, 2009 – Kenneth D. Miller, MD
Program Keeps Tabs on Childhood Cancer Survivors
June 09, 2009 – Lacey Meyer
With a Friend Like Will Ferrell...
June 09, 2009 – Lacey Meyer
www.armyofwomen.org
June 09, 2009 – Elizabeth Whittington
Q & A: Prostate Cancer Screening
June 09, 2009 – Len Lichtenfeld, MD
Ovarian Cancer Survivors Course
June 09, 2009
The Financial Advocate
June 09, 2009 – Kathy LaTour
Interventions Needed to Get Survivors Moving
June 09, 2009 – Lena Huang
ASCO Updates
June 09, 2009 – Staff Reports
No I.D.
June 09, 2009 – Katy Human
Disjointed Custody
June 09, 2009 – Charlotte Huff
Fighting Fatigue
June 09, 2009 – Lena Huang
Reconstruction Do-Overs
June 09, 2009 – Kathy LaTour
Hard Times
June 09, 2009 – Joanne Kenen
What About CUP Patients?
June 09, 2009 – Katy Human
Weighing the Techniques
June 09, 2009 – Charlotte Huff
Hair Loss Snapshot
June 09, 2009 – Lacey Meyer
Surgical Strategies
June 09, 2009 – Karen Patterson
Taking a Closer Look
June 09, 2009 – Karen Patterson
From Cancer Warrior to Basketball Player
June 09, 2009 – Deirdre Carey
Resources
June 09, 2009
Sticker Shock
June 09, 2009 – Laura Beil
Smarter Trials for Smarter Drugs
June 09, 2009 – Laura Beil
How to Find a Cancer Trainer
June 09, 2009 – Lena Huang
P.S. A Word About Implants & Some Unanswered Questions
June 09, 2009 – Kathy LaTour
Resources
June 09, 2009
Cancer Research Receives Infusion of Federal Funds
June 15, 2009 – Lacey Meyer
Improved Care Needed for Patients Receiving Heart-Toxic Drugs
June 15, 2009 – Melissa Weber
Chicken Soup for the Soul: The Cancer Book
June 15, 2009 – Kathy LaTour
Childhood Cancer Survivorship Programs
June 16, 2009
Currently Viewing
Web Exclusive: Clinical Trials for CUP
June 16, 2009
Web Exclusive: An Infection Out of Nowhere
June 16, 2009
Excerpt: Stronger
June 17, 2009 – Natalie Flechsig
Web Exclusive: The Voice on the Other End of the Phone
June 18, 2009 – Dianne Ericson
Web Exclusive: A Peaceful Spirit
June 18, 2009 – Toby Bressler, RN, BSN, OCN
Web Exclusive: Fertility Guidelines Not Meeting Needs of Patients
June 22, 2009 – Elizabeth Whittington
Web Exclusive: When Survivors Should Exercise Caution
June 22, 2009 – Lena Huang
Web Exclusive: Searching for New Targets
June 23, 2009 – Elizabeth Whittington
Web Exclusive: Developing a Strategy
June 25, 2009 – Elizabeth Whittington
Web Exclusive: Helpful Advice
June 25, 2009 – Elizabeth Whittington
Web Exclusive: Types of Kidney Cancer
June 25, 2009 – The American Cancer Society
Web Exclusive: A Q&A with an Extraordinary Healer
June 30, 2009 – Kathy LaTour
Web Exclusive: Find a Clinical Trial That's Right for You
July 09, 2009
Web Exclusive: Find a Clinical Trial That's Right for You
July 09, 2009

Web Exclusive: Clinical Trials for CUP

Clinical trials for cancers of unknown primary patients. 

PUBLISHED June 16, 2009

A listing of clinical trials for patients with cancers of unknown primary are listed below.  

 

Therapy: Treatment based on molecular profiling assay – paclitaxel, carboplatin, bevacizumab, erlotinib
Cancer: Carcinoma of Unknown Primary
Phase: II
Sponsor/Manufacturer: Sarah Cannon Research Institute/Genentech
Contact information: John D. Hainsworth, MD, 615-329-7274; jhainsworth@tnonc.com

Therapy: Avastin (bevacizumab)
Cancer: Neuroendocrine Carcinoma
Phase: III
Sponsor/Manufacturer: Southwest Oncology Group, National Cancer Institute
Contact information: James Yao, MD, 713-792-2828; jyao@mdanderson.org or 800-392-1611

Therapy: Taxotere (docetaxel), 5-FU (5-fluorouracil), Platinol (cisplatin)
Cancer: Squamous Cell or Undifferentiated Carcinoma
Phase: II
Sponsor/Manufacturer: M.D. Anderson Cancer Center/Sanofi-Aventis
Contact information: Ehab Y. Hanna, MD, 713-745-2672; eyhanna@mdanderson.org

Therapy: Xeloda (capecitabine)
Cancer: Solid Tumors and Adenocarcinoma of Unknown Primary
Phase: I/II
Sponsor/Manufacturer: Ohio State University Comprehensive Cancer Center
Contact information: OSU Cancer Clinical Trial Matching Service – 866-627-7616; osu@emergingmed.com

Therapy: Vectibix (panitumumab)
Cancer: Squamous Cell Carcinoma of the Head and Neck; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma
Phase: I
Sponsor/Manufacturer: Dana-Farber Cancer Institute; Brigham and Women’s Hospital; Massachusetts General Hospital/Amgen
Contact information: Lori J. Wirth, MD, 617-632-3090; lwirth@partners.org

Therapy: Nexavar (sorafenib)
Cancer: Advanced Solid Tumors
Phase: II
Sponsor/Manufacturer: University of California Davis
Contact information: UC Davis Clinical Trials Office – 916-734-3089 or Primo N. Lara, MD, 916-734-3772; primo.lara@ucdmc.ucdavis.edu

Therapy: Stereotactic Body Radiotherapy
Cancer: Spinal Neoplasms
Phase: I/II
Sponsor/Manufacturer: M.D. Anderson Cancer Center
Contact information: Eric L. Chang, MD, 713-563-2300; echang@mdanderson.org 

 

Investigators in clinical trials may be individual physicians, researchers at institutions, or pharmaceutical company representatives. The contact information given here was provided by those running these trials and was accurate at the time of publication. If you get a voice mail, leave the pertinent information. For additional trials, go to www.curetoday.com/trialcheck.

Continue the conversation on CURE’s forum. >>
Talk about this article with other patients, caregivers, and advocates in the CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In